3.12. Comparison of adverse reactions between the 2 groups
thrombocytopenia, nausea, vomiting, RA
ADVERSE EVENTS, THROMBOCYTOPENIA, ADVERSE REACTION, ADVERSE REACTIONS
There were no adverse events that seriously affected the treatment of patients in both groups. Two patients had a mild elevation of glutamate transaminase, 1 patient had nausea, and 1 patient had thrombocytopenia during the treatment in the treatment group, and the incidence of adverse reactions was 8.2%. In the control group, 2 patients had a mild elevation of glutamate transaminase, and 1 patient had vomiting during the treatment period, with an adverse reaction incidence of 6.0%. All of them received symptomatic treatment, which did not affect RA treatment, and there was no significant difference in the incidence of adverse reactions between the 2 groups.